The periodical about the pharmaceutical and medical equipment markets
(Russian pharmacies) - specialized periodical edition for pgarmacy professionals
Medical Council - Scientific Journal for Physicians
In Russia, the vast majority of pharmaceutical sales are attributed to imported drugs, something that President Vladimir Putin’s “Pharma 2020” project - an initiative to stimulate local pharmaceutical development and manufacturing - aims to change.
On April 28, 2017, Courtyard Moscow City Center will host the third conference M-Health Congress. It will bring together various experts in the field of digital healthcare: doctors and scientists, entrepreneurs and startupers, developers of medical gadgets and software. The event will include the discussion of key developments of the industry.
A British-Russian consortium said on Tuesday they are close to an agreement for the purchase of 25% of Serbian majority state-owned drug maker Galenika, despite the government's recent announcement that the talks over the sale have failed
Drug prices in Russia may increase by 20%-25% this year, due to the implementation of the latest state initiative for the introduction of mandatory QR-labelling on drugs in the local market, according to recent statements by local producers and analysts in the field of pharmaceutics.
6 - 10 из 882
Russia’s leading biotech firm Biocad is finishing clinical trials of a new anti-cancer drug that will soon appear in the Russian market and will be able to compete with imported analogues.
programmer of electronic software products